Imagion Non-Executive Director Mike Harsh tracks the history of imaging technologies
https://vimeo.com/376689656
Imagion Podcast Episode 2: Mike Harsh speaks with Marisa Zammit from WE Communications
Marisa Zammit asks Mike about his background, how Mike came to join Imagion and how Mike thinks Imagion's technology could transform the imaging industry.…
Imagion Non-Executive Director Mike Harsh details how MagSense is the sixth way of imaging
https://vimeo.com/376689315
Imagion Biosystems receives $300K order for supply of nanoparticles
Imagion Biosystems Limited announced the NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has placed an order totaling…
Imagion features in Mergermarkets
Imagion CEO Bob Proulx discusses the company's path to first-in-human trials plus early discussions with potential partners and strategic investors in this…
Mike Harsh Addresses Investors in Sydney, Australia
Non-Executive Director Mike Harsh addresses Imagion Biosystems' investors. November, 2019.
Finfeed interview with Mike Harsh
Interview: Mike Harsh on the evolution of Imaging and Imagion's role With over 40 years' experience in the health care diagnostic imaging industry, Imagion…
Bob Proulx Discusses Imagion's Recent Progress with Boardroom Media
Funds raised in Imagion’s recent Rights Issue will be used to fund the first-in-human trials for the Company’s MagSense technology. Listen to CEO Bob Proulx…
Imagion Biosystems' Patent Issued in India
Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, has been issued patent #320872 from…